Brian C. Broderick’s Korsana Biosciences KRSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
– Sell
-230
Closed -$99K – 78
2021
Q3
$99K Hold
230
– – 0.03% 80
2021
Q2
$126K Hold
230
– – 0.03% 80
2021
Q1
$90K Hold
230
– – 0.03% 79
2020
Q4
$98K Hold
230
– – 0.03% 77
2020
Q3
$196K Hold
230
– – 0.06% 84
2020
Q2
$190K Hold
230
– – 0.06% 81
2020
Q1
$86K Hold
230
– – 0.03% 76
2019
Q4
$88K Sell
230
-5
-2% -$3.27K 0.03% 85
2019
Q3
$399K Hold
235
– – 0.14% 65
2019
Q2
$377K Buy
+235
New +$466K 0.13% 64

Other funds holding KRSA

Brian C. Broderick's KRSA Position: Q4 2021 in Review

Brian C. Broderick sold out of Korsana Biosciences (KRSA) in Q4 2021, closing a stake of 230 shares — an estimated $99K sold.

Brian C. Broderick first reported a position in KRSA in Q2 2019 and held it in 10 quarters. The position peaked at $399K in Q3 2019. 51 funds tracked by Wall St. Rank hold KRSA as of Q4 2021.

  • Brian C. Broderick reported no remaining Korsana Biosciences position as of Q4 2021 after selling out during the quarter.
  • Brian C. Broderick sold 230 Korsana Biosciences shares in Q4 2021, an estimated $99K.
  • Brian C. Broderick first reported a position in Korsana Biosciences in Q2 2019 and held it in 10 quarters.
  • Brian C. Broderick's Korsana Biosciences position peaked at $399K in Q3 2019.
  • 51 funds tracked by Wall St. Rank held Korsana Biosciences as of Q4 2021.

Based on Brian C. Broderick's 13F filing for Q4 2021, filed 8 Feb 2022.